PCSK9 Tx — Ready for Prime Time or Still Unproven?

ACC Conference Reporter

ESC Congress 2016 | ROME — Are PSCK9 inhibitors ready for widespread use, or should a major roll-out of the high priced cholesterol-lowering agents beput on hold until definitive outcome studies are done? Read More >>>

Keywords: ESC Congress

< Back to Listings